Author Krasemann, Susanne
-
2023 | Journal Article |
Expansion-enhanced super-resolution radial fluctuations enable nanoscale molecular profiling of pathology specimens
Kylies, D.; Zimmermann, M.; Haas, F.; Schwerk, M.; Kuehl, M.; Brehler, M. & Czogalla, J. et al. (2023)
Nature Nanotechnology,. DOI: https://doi.org/10.1038/s41565-023-01328-z
Details DOI PMID PMC
-
2020 | Journal Article | Research Paper
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
Matschke, J.; Lütgehetmann, M.; Hagel, C.; Sperhake, J. P; Schröder, A. S.; Edler, C. & Mushumba, H. et al. (2020)
The Lancet. Neurology, 19(11) pp. 919-929. DOI: https://doi.org/10.1016/S1474-4422(20)30308-2
Details DOI
-
2018 | Journal Article
Distinct microglia profile in Creutzfeldt–Jakob disease and Alzheimer's disease is independent of disease kinetics
Krbot, K.; Hermann, P.; Skorić, M. K.; Zerr, I.; Sepulveda‐Falla, D.; Goebel, S. & Matschke, J. et al. (2018)
Neuropathology, 38(6) pp. 591-600. DOI: https://doi.org/10.1111/neup.12517
Details DOI
-
2017 | Journal Article |
YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
Llorens, F.; Thüne, K.; Tahir, W.; Kanata, E.; Diaz-Lucena, D.; Xanthopoulos, K. & Kovatsi, E. et al. (2017)
Molecular Neurodegeneration, 12(1) art. 83. DOI: https://doi.org/10.1186/s13024-017-0226-4
Details DOI
-
2016 | Journal Article
Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity
Falker, C.; Hartmann, A. K.; Guett, I.; Dohler, F.; Altmeppen, H.; Betzel, C. & Schubert, R. et al. (2016)
Journal of Neurochemistry, 137(1) pp. 88-100. DOI: https://doi.org/10.1111/jnc.13514
Details DOI PMID PMC WoS
-
2014 | Conference Abstract
Selective binding of high molecular mass assemblies of amyloid beta-peptide to prion protein in patients with Alzheimer's disease
Dohler, F.; Sepulveda-Falla, D.; Krasemann, S.; Altmeppen, H.; Schlueter, H.; Zerr, I. & Matschke, J. et al. (2014)
Prion, 8 pp. 134-135.
Austin: Landes Bioscience.
Details WoS
-
2014 | Journal Article |
No reactivation of JCV and CMV infections in the temporal cortex and cerebellum of sporadic Creutzfeldt-Jakob disease patients.
Löffler, J.; Krasemann, S.; Zerr, I.; Matschke, J. & Glatzel, M. (2014)
American journal of neurodegenerative disease, 3(3) pp. 152-157.
Details PMID PMC
-
2014 | Journal Article
High molecular mass assemblies of amyloid-beta oligomers bind prion protein in patients with Alzheimer's disease
Dohler, F.; Sepulveda-Falla, D.; Krasemann, S.; Altmeppen, H.; Schlueter, H.; Hildebrand, D. & Zerr, I. et al. (2014)
Brain, 137 pp. 873-886. DOI: https://doi.org/10.1093/brain/awt375
Details DOI PMID PMC WoS
-
2013 | Journal Article
BSE-associated Prion-Amyloid Cardiomyopathy in Primates
Krasemann, S.; Mearini, G.; Kraemer, E.; Wagenfuehr, K.; Schulz-Schaeffer, W. J.; Neumann, M. & Bodemer, W. et al. (2013)
EMERGING INFECTIOUS DISEASES, 19(6) pp. 985-988. DOI: https://doi.org/10.3201/eid1906.120906
Details DOI PMID PMC WoS
-
2010 | Journal Article |
Preclinical Deposition of Pathological Prion Protein in Muscle of Experimentally Infected Primates
Krasemann, S.; Neumann, M.; Geissen, M.; Bodemer, W. ; Kaup, F.-J.; Schulz-Schaeffer, W. J. & Morel, N. et al. (2010)
PLoS ONE, 5(11) art. e13906. DOI: https://doi.org/10.1371/journal.pone.0013906
Details DOI PMID PMC WoS
-
2002 | Journal Article
Recombinant human prion protein mutants huPrP D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase K resistance
Gauczynski, S.; Krasemann, S.; Bodemer, W. & Weiss, S. (2002)
Journal of Cell Science, 115(21) pp. 4025-4036. DOI: https://doi.org/10.1242/jcs.00086
Details DOI
-
1996 | Journal Article
Induction of antibodies against human prion proteins (PrP) by DNA-mediated immunization of mice
Krasemann, S.; Groschup, M.; Hunsmann, G. & Bodemer, W. (1996)
Journal of Immunological Methods, 199(2) pp. 109-118. DOI: https://doi.org/10.1016/S0022-1759(96)00165-2
Details DOI